{"id":2786,"date":"2024-10-11T06:54:17","date_gmt":"2024-10-11T06:54:17","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/pharmacovigilance-of-veterinary-medicinal-products-management-of-adverse-event-reports-aers\/"},"modified":"2024-10-23T10:42:02","modified_gmt":"2024-10-23T10:42:02","slug":"pharmacovigilance-of-veterinary-medicinal-products-management-of-adverse-event-reports-aers","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/pharmacovigilance-of-veterinary-medicinal-products-management-of-adverse-event-reports-aers\/","title":{"rendered":"Pharmacovigilance des m\u00e9dicaments v\u00e9t\u00e9rinaires : gestion des signalements d\u2019\u00e9v\u00e9nements ind\u00e9sirables"},"content":{"rendered":"<p>VICH GL24 (Pharmacovigilance) &#8211; Octobre 2007 &#8211; Mise en \u0153uvre en d\u00e9cembre 2015<\/p>\n","protected":false},"menu_order":30,"template":"","meta":[],"guideline_category":[276],"class_list":["post-2786","guideline","type-guideline","status-publish","hentry","guideline_category-pharmacovigilance-vich-gls-24-29-35-42-fr"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/2786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=2786"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=2786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}